- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ZN: ZINC ION(Non-covalent)
- 5 x W02: 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL(Non-covalent)
W02.2: 15 residues within 4Å:- Chain A: I.77, I.98, L.100, I.122, M.124, Y.142, Y.144, A.166, V.168, F.179, L.181, L.184, Y.190, M.214, L.217
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:I.77, A:I.98, A:L.100, A:I.122, A:Y.144, A:Y.144, A:Y.144, A:A.166, A:V.168, A:L.181, A:L.184, A:Y.190
- Water bridges: A:N.212
- pi-Stacking: A:Y.190
W02.5: 15 residues within 4Å:- Chain E: I.77, I.98, L.100, I.122, M.124, Y.142, Y.144, A.166, V.168, F.179, L.181, L.184, Y.190, M.214, L.217
14 PLIP interactions:14 interactions with chain E- Hydrophobic interactions: E:I.77, E:I.98, E:L.100, E:I.122, E:Y.144, E:Y.144, E:Y.144, E:A.166, E:V.168, E:L.181, E:L.184, E:Y.190
- Water bridges: E:N.212
- pi-Stacking: E:Y.190
W02.8: 15 residues within 4Å:- Chain I: I.77, I.98, L.100, I.122, M.124, Y.142, Y.144, A.166, V.168, F.179, L.181, L.184, Y.190, M.214, L.217
14 PLIP interactions:14 interactions with chain I- Hydrophobic interactions: I:I.77, I:I.98, I:L.100, I:I.122, I:Y.144, I:Y.144, I:Y.144, I:A.166, I:V.168, I:L.181, I:L.184, I:Y.190
- Water bridges: I:N.212
- pi-Stacking: I:Y.190
W02.11: 15 residues within 4Å:- Chain M: I.77, I.98, L.100, I.122, M.124, Y.142, Y.144, A.166, V.168, F.179, L.181, L.184, Y.190, M.214, L.217
14 PLIP interactions:14 interactions with chain M- Hydrophobic interactions: M:I.77, M:I.98, M:L.100, M:I.122, M:Y.144, M:Y.144, M:Y.144, M:A.166, M:V.168, M:L.181, M:L.184, M:Y.190
- Water bridges: M:N.212
- pi-Stacking: M:Y.190
W02.14: 15 residues within 4Å:- Chain Q: I.77, I.98, L.100, I.122, M.124, Y.142, Y.144, A.166, V.168, F.179, L.181, L.184, Y.190, M.214, L.217
14 PLIP interactions:14 interactions with chain Q- Hydrophobic interactions: Q:I.77, Q:I.98, Q:L.100, Q:I.122, Q:Y.144, Q:Y.144, Q:Y.144, Q:A.166, Q:V.168, Q:L.181, Q:L.184, Q:Y.190
- Water bridges: Q:N.212
- pi-Stacking: Q:Y.190
- 5 x MYR: MYRISTIC ACID(Covalent)
MYR.3: 11 residues within 4Å:- Chain D: G.1, N.30
- Chain E: Y.6
- Chain H: Y.26, F.27, I.29, Y.31
- Chain L: F.27
- Chain O: L.2
- Ligands: MYR.6, MYR.15
5 PLIP interactions:2 interactions with chain H, 1 interactions with chain O, 1 interactions with chain L, 1 interactions with chain E- Hydrophobic interactions: H:Y.26, H:F.27, O:L.2, L:F.27
- Hydrogen bonds: E:Y.6
MYR.6: 11 residues within 4Å:- Chain H: G.1, N.30
- Chain I: Y.6
- Chain L: Y.26, F.27, I.29, Y.31
- Chain P: F.27
- Chain S: L.2
- Ligands: MYR.3, MYR.9
4 PLIP interactions:1 interactions with chain P, 1 interactions with chain S, 2 interactions with chain L- Hydrophobic interactions: P:F.27, S:L.2, L:Y.26, L:F.27
MYR.9: 11 residues within 4Å:- Chain C: L.2
- Chain L: G.1, N.30
- Chain M: Y.6
- Chain P: Y.26, F.27, I.29, Y.31
- Chain T: F.27
- Ligands: MYR.6, MYR.12
4 PLIP interactions:1 interactions with chain C, 2 interactions with chain P, 1 interactions with chain T- Hydrophobic interactions: C:L.2, P:Y.26, P:F.27, T:F.27
MYR.12: 11 residues within 4Å:- Chain D: F.27
- Chain G: L.2
- Chain P: G.1, N.30
- Chain Q: Y.6
- Chain T: Y.26, F.27, I.29, Y.31
- Ligands: MYR.9, MYR.15
4 PLIP interactions:1 interactions with chain G, 2 interactions with chain T, 1 interactions with chain D- Hydrophobic interactions: G:L.2, T:Y.26, T:F.27, D:F.27
MYR.15: 11 residues within 4Å:- Chain A: Y.6
- Chain D: Y.26, F.27, I.29, Y.31
- Chain H: F.27
- Chain K: L.2
- Chain T: G.1, N.30
- Ligands: MYR.3, MYR.12
5 PLIP interactions:1 interactions with chain K, 1 interactions with chain A, 2 interactions with chain D, 1 interactions with chain H- Hydrophobic interactions: K:L.2, D:Y.26, D:F.27, H:F.27
- Hydrogen bonds: A:Y.6
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hadfield, A.T. et al., Analysis of Three Structurally Related Antiviral Compounds in Complex with Human Rhinovirus 16. Proc.Natl.Acad.Sci.USA (1999)
- Release Date
- 1999-07-20
- Peptides
- PROTEIN VP1: AEIMQ
PROTEIN VP2: BFJNR
PROTEIN VP3: CGKOS
PROTEIN VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ZN: ZINC ION(Non-covalent)
- 5 x W02: 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL(Non-covalent)
- 5 x MYR: MYRISTIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hadfield, A.T. et al., Analysis of Three Structurally Related Antiviral Compounds in Complex with Human Rhinovirus 16. Proc.Natl.Acad.Sci.USA (1999)
- Release Date
- 1999-07-20
- Peptides
- PROTEIN VP1: AEIMQ
PROTEIN VP2: BFJNR
PROTEIN VP3: CGKOS
PROTEIN VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4